Related references
Note: Only part of the references are listed.Amino acid analysis of peptide loading ratios in conjugate vaccines: A comparison of direct electrochemical detection and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate pre-column derivatization methods
Deborah D. Nahas et al.
BIOCONJUGATE CHEMISTRY (2008)
Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGN
Sheng-Kai Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
Victoria R. Polonis et al.
VIROLOGY (2008)
Fully synthetic carbohydrate HIV antigens designed on the logic of the 2G12 antibody
Isaac J. Krauss et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Structure of a high-affinity Mimotope peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies
Erica Ollmann Saphire et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Novel template-assembled oligosaccharide clusters as epitope mimics for HIV-neutralizing antibody 2G12. Design, synthesis, and antibody binding study
Jingsong Wang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2007)
Virus glycosylation: role in virulence and immune interactions
David J. Vigerust et al.
TRENDS IN MICROBIOLOGY (2007)
Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12
Dana Huskens et al.
VIROLOGY (2007)
Design of immunogens that present the crown of the HIV-1V3 loop in a conformation competent to generate 447-52D-like antibodies
Kausik Chakraborty et al.
BIOCHEMICAL JOURNAL (2006)
Toward a carbohydrate-based HIV-1 vaccine: Synthesis and immunological studies of oligomannose-containing glycoconjugates
JH Ni et al.
BIOCONJUGATE CHEMISTRY (2006)
Immunogenicity and protective efficacy of Bacillus anthracis poly-γ-D-glutamic acid capsule covalently coupled to a protein carrier using a novel triazine-based conjugation strategy
J Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A rationally designed synthetic mimic of the discontinuous CD4-binding site of HIV-1 gp120
Raimo Franke et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2006)
Dissection of the carbohydrate specificity of the broadly neutralizing-anti-HIV-1 antibody 2G12
DA Calarese et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis
J Balzarini et al.
MOLECULAR PHARMACOLOGY (2005)
Role of Neutralizing Antibodies in Protective Immunity Against HIV
Indresh K. Srivastava et al.
HUMAN VACCINES (2005)
Broadly neutralizing anti-HIV antibody 4E10 recognizes a helical conformation of a highly conserved fusion-associated motif in gp41
RMF Cardoso et al.
IMMUNITY (2005)
Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay
D Opalka et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human Toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity
E Latz et al.
JOURNAL OF IMMUNOLOGY (2004)
Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
JA Fan et al.
VACCINE (2004)
Toward fully synthetic carbohydrate-based HIV antigen design: On the critical role of bivalency
VY Dudkin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies
AA Nabatov et al.
JOURNAL OF VIROLOGY (2004)
In pursuit of carbohydrate-based HIV vaccines, Part 1: The total synthesis of hybrid-type gp120 fragments
M Mandal et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
In pursuit of carbohydrate-based HIV vaccines, Part 2: The total synthesis of high-mannose-type gp120 fragments-evaluation of strategies directed to maximal convergence
XD Geng et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Antibody domain exchange is an immunological solution to carbohydrate cluster recognition
DA Calarese et al.
SCIENCE (2003)
Therapeutic potential of neutralizing antibodies in the treatment of HIV-1 infection
G Stiegler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Enhancement of α-helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro -: Implications for vaccine design
JG Joyce et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120
CN Scanlan et al.
JOURNAL OF VIROLOGY (2002)
Effect of individual conjugate dose on immunogenicity of type 6B pneumococcal polysaccharide-N-meningitidis outer membrane protein complex conjugate vaccines in infant rhesus monkeys
TB McNeely et al.
VACCINE (2000)
Share Paper
